ArticleThoracic cancer2019

Chemotherapy combined with Endostar as salvage treatment for EGFR-tyrosine kinase inhibitor primary resistance in an advanced non-small cell lung cancer patient with EGFR L858R mutation and ROS1 fusion: A case report.

Dong Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.